For the latter, schizophrenia patients show enhanced D2 dopamine receptors (D2R)‐mediated dopaminergic activity but a deficit in D1R‐mediated dopaminergic activity (Toda and Abi‐Dargham 2007). This evidence concerns the gene DRD2 and schizophrenia.